000 00935 a2200277 4500
005 20250517212214.0
264 0 _c20190711
008 201907s 0 0 eng d
022 _a2326-5205
024 7 _a10.1002/art.40526
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLeijten, E F A
245 0 0 _aEditorial: Lessons Learned From a "Failed" Clinical Trial.
_h[electronic resource]
260 _bArthritis & rheumatology (Hoboken, N.J.)
_c09 2018
300 _a1364-1365 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aArthritis, Rheumatoid
650 0 4 _aBiomarkers
650 0 4 _aDrug Development
650 0 4 _aHumans
650 0 4 _aProteomics
700 1 _aRadstake, T R D J
700 1 _aReedquist, K A
773 0 _tArthritis & rheumatology (Hoboken, N.J.)
_gvol. 70
_gno. 9
_gp. 1364-1365
856 4 0 _uhttps://doi.org/10.1002/art.40526
_zAvailable from publisher's website
999 _c28301097
_d28301097